Pure Global
NCT06360770

Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia

Assessement of Microcirculation With NIRS Predicts Sepsis Development in Mechanically Ventilated Patients With Severe Covid-19 Pneumonia
General and Teaching Hospital Celje·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Sepsis
Study type
Observational
Sponsor & location
Primary sponsor
General and Teaching Hospital Celje
Location
Celje, Slovenia
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2021
End date
Apr 30, 2023
Enrollment
35 participants
Primary outcome

sepsis development

Summary

Sepsis and septic shock are among main causes of death in patients with severe Covid-19
 pneumonia. A few factors are proven to predict sepsis in these patients. WIth near infrared
 spectroscopy it is possible to detect microcirculatory changes typical for sepsis early in
 the course of disease. The hypothesis that changes in tissue oxygene saturation during
 vasoocclusive test predict sepsis as well as mortality in mechancally ventilated patients
 withe severe Covid-19 pneumonia will be tested.

ICD-10 classifications
Other sepsisSepsis, unspecifiedOther specified sepsisCandidal sepsisPuerperal sepsis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06360770
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06360770 through Pure Global AI's free database. This phase not specified trial is sponsored by General and Teaching Hospital Celje and is currently Completed. The study focuses on Sepsis. Target enrollment is 35 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.